Novartis PKC412 (midostaurin) data show 60 per cent response rate in advanced systemic mastocytosis
There is further evidence of potential benefit in rare blood cancers; regulatory submissions for advanced SM and acute myeloid…
Author
RPG Life Sciences announces foray into cosmetic industry
Ties up with Italy-based Labo Cosprophar, to launch two new products for hair & skin care
RPG Life Sciences has announced its…
‘Almost all major manufacturers of pharma products in India have acknowledged and responded to…
Javin Bhinde, MD & CEO, SynCore Consulting shares details of the PatientSafe India conference this year and its objectives. He…
‘Our courses are specially designed for Indian conditions’
The Contamination Control Society of India (CCSI) has started training programmes for production and supervision staff of…
SNEC30 was prepared with the use of the self nano emulsifying drug delivery system
Arbro Pharmaceuticals recently launched SNEC30, a Curcumin formulation in 30 mg dose. Dr Saurabh Arora, Executive Director, Arbro…
‘Pharmalytics is an end-to-end analytics platform providing localised data of the demand and…
CareOnGo, a mobile chain of co-branded pharmacy stores, recently launched a pharmalytics platform, Aditya Kandoi, Co founder at…
Jardiance (empagliflozin) reduces risk of progressive kidney disease in adults with type 2 diabetes…
Jardiance (empagliflozin) is the only SGLT2 inhibitor to demonstrate the potential to improve kidney outcomes on top of standard…
Low dose of stem cells might provide relief from arthritis of the knee
The study aimed to evaluate the safety and effectiveness of different doses of a type of stem cell called adipose-derived stromal…
FDA approves vaccine to prevent cholera for travelers
Vaxchora, the only FDA-approved vaccine for the prevention of cholere, is a live, weakened vaccine that is taken as a single, oral…
Polaris Group reports phase III study results of ADI-PEG 20 plus best supportive care in advanced…
The full study results were presented at the American Society of Clinical Oncology's 2016 annual meeting in Chicago
Polaris Group…